Concepedia

Karen Sielaff

KS

Statistics

Publications

9

Citations

432

H-Index

9

Active since

1985

Affiliations

University of Wisconsin–Madison(Current)

Karen Sielaff is an author at University of Wisconsin–Madison specializing in pharmacology, interferon-based therapy, and immunology.

Publications per year

1985–2010

9

Publications

9

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Skin Cancer Prevention Study of α-Difluoromethylornithine in Subjects with Previous History of Skin Cancer

Howard H. Bailey, KyungMann Kim, Ajit Kumar Verma et al. · Cancer Prevention Research · 2010 · 111 citations · Full text

, , +15

Human Biologic Response Modification by Interferon in the Absence of Measurable Serum Concentrations: A Comparative Trial of Subcutaneous and Intravenous Interferon-beta serine

Daniel A. Goldstein, Karen Sielaff, B. E. Stores et al. · JNCI Journal of the National Cancer Institute · 1989 · 76 citations

, , +12

Phase I evaluation of a synthetic mutant of beta-interferon.

Michael Hawkins, Sandra J. Horning, Michael Konrad et al. · PubMed · 1985 · 60 citations

, , +15

Phase II trial of interferon-β for treatment of recurrent glioblastoma multiforme

Thomas A. Duff, Ernest C. Borden, Janet W. Bay et al. · Journal of neurosurgery · 1986 · 46 citations

, , +17

Modulation of 2′,5′-Oligoadenylate Synthetase in Patients Treated with Alpha-Interferon: Effects of Dose, Schedule, and Route of Administration

James A. Merritt, L. Andrew Ball, Karen Sielaff et al. · Journal of Interferon Research · 1986 · 38 citations

, , +15

1–5 of 9